A chronic <i>Pseudomonas aeruginosa</i> mouse lung infection modeling the mucus obstruction, lung function, and inflammation of human cystic fibrosis

Mouse models of cystic fibrosis (CF) have been used to study chronic lung infections; however, these models have lacked the airway mucus that defines human CF pathophysiology and required the use of mucoid <i>Pseudomonas aeruginosa</i>. Alternative models have used either transgenic <i>Scnn1b-Tg</i> mice overexpressing a lung epithelial sodium channel to mimic the mucus-rich CF lung environment, synthetic CF sputum medium (SCFM2) to induce bacterial phenotypes consistent with human CF, or agar beads to promote chronic infections by non-mucoid <i>P. aeruginosa</i>. Here, we combined these alternative models and established a chronic <i>P. aeruginosa</i> lung infection model using SCFM2 agar beads and <i>Scnn1b-</i>Tg mice (SCFM2-<i>Scnn1b-</i>Tg) to recapitulate nutrient and mucus characteristics of the human CF lung environment and test the effects of chronic infections on bacterial burden, lung function, and the immune response. Using wild-type SCFM2-C57BL/6 mice as controls, SCFM2-<i>Scnn1b-</i>Tg mice failed to clear bacterial infections, and lung function measurements showed that infected SCFM2-<i>Scnn1b-</i>Tg mice had decreased inspiratory capacity and compliance, elevated airway resistance, and significantly reduced forced expiratory volumes. Flow cytometry and cytokine arrays showed that, like people with CF, SCFM2-<i>Scnn1b-</i>Tg mice developed inflammation characterized by neutrophil and eosinophil infiltration and Th2 lymphocytic cytokine responses. Chronically infected SCFM2-<i>Scnn1b-</i>Tg mice developed an exacerbated mix of innate and Th1, Th2, and Th17-mediated inflammation, causing higher lung cellular damage and elevated numbers of unusual Siglec F<sup>+</sup> neutrophils. SCFM2-<i>Scnn1b-</i>Tg mice will be useful for investigating bacterial pathogenesis by non-mucoid <i>P. aeruginosa</i>, including treatments and the roles of Siglec F<sup>+</sup> neutrophils in CF inflammation.

Authors

Institutions

Publication Details

Journal
Infection and Immunity
Published
2025-06-13
DOI
https://doi.org/10.1128/iai.00230-25
Citations
7
Primary Topic
Cystic Fibrosis Research Advances
Type
article
Field-Weighted Citation Impact
10.63

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A chronic Pseudomonas aeruginosa mouse lung infection modeling the mucus obstruction, lung function, and inflammation of human cystic fibrosis

Anna Clara Milesi Galdino, Peter Jorth, Diane Aguilar, Sheryl Erica Fernandes et al.
7 citations
Infection and Immunity
Cystic Fibrosis Research Advances
10.63
article

A chronic Pseudomonas aeruginosa mouse lung infection modeling the mucus obstruction, lung function, and inflammation of human cystic fibrosis

Anna Clara Milesi Galdino, Peter Jorth, Diane Aguilar, Sheryl Erica Fernandes, Mylène Vaillancourt
article en
7 citations

Abstract

Mouse models of cystic fibrosis (CF) have been used to study chronic lung infections; however, these models have lacked the airway mucus that defines human CF pathophysiology and required the use of mucoid <i>Pseudomonas aeruginosa</i>. Alternative models have used either transgenic <i>Scnn1b-Tg</i> mice overexpressing a lung epithelial sodium channel to mimic the mucus-rich CF lung environment, synthetic CF sputum medium (SCFM2) to induce bacterial phenotypes consistent with human CF, or agar beads to promote chronic infections by non-mucoid <i>P. aeruginosa</i>. Here, we combined these alternative models and established a chronic <i>P. aeruginosa</i> lung infection model using SCFM2 agar beads and <i>Scnn1b-</i>Tg mice (SCFM2-<i>Scnn1b-</i>Tg) to recapitulate nutrient and mucus characteristics of the human CF lung environment and test the effects of chronic infections on bacterial burden, lung function, and the immune response. Using wild-type SCFM2-C57BL/6 mice as controls, SCFM2-<i>Scnn1b-</i>Tg mice failed to clear bacterial infections, and lung function measurements showed that infected SCFM2-<i>Scnn1b-</i>Tg mice had decreased inspiratory capacity and compliance, elevated airway resistance, and significantly reduced forced expiratory volumes. Flow cytometry and cytokine arrays showed that, like people with CF, SCFM2-<i>Scnn1b-</i>Tg mice developed inflammation characterized by neutrophil and eosinophil infiltration and Th2 lymphocytic cytokine responses. Chronically infected SCFM2-<i>Scnn1b-</i>Tg mice developed an exacerbated mix of innate and Th1, Th2, and Th17-mediated inflammation, causing higher lung cellular damage and elevated numbers of unusual Siglec F<sup>+</sup> neutrophils. SCFM2-<i>Scnn1b-</i>Tg mice will be useful for investigating bacterial pathogenesis by non-mucoid <i>P. aeruginosa</i>, including treatments and the roles of Siglec F<sup>+</sup> neutrophils in CF inflammation.

Infection and ImmunityVol. 93(7)
Cedars-Sinai Medical Center (US)
Cystic Fibrosis Foundation, National Institute of Allergy and Infectious Diseases
Openalex Percentile: Top 1%
Cystic Fibrosis Research Advances
10.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.